Thomas Renné
3Patents
2h-index
1Co-inventors
34Inventor score
Filing activity: Dec 20, 2005 → Jun 28, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8119137B2 | Prevention of thrombus formation and/or stabilization with inhibitors of factor XII or activated factor XII | Emerging Cross-Sectional Technologies | 6 | Active |
| US8715672B2 | Treatment of diseases linked to pathological kinin formation | Emerging Cross-Sectional Technologies | 3 | Active |
| US11846641B2 | Binding molecule activating FXII | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.